中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

83 records (took 0.034 seconds)

    DIALYSIS TREATMENT DEVICES FOR REMOVING UREA
    31.
    发明申请
    DIALYSIS TREATMENT DEVICES FOR REMOVING UREA 有权
    用于去除尿素的DIALYSIS治疗装置

    公开(公告)号：US20120055864A1

    公开(公告)日：2012-03-08

    申请号：US13296522

    申请日：2011-11-15

    Applicant: Yuanpang Samuel Ding ,  Ying-Cheng Lo

    Inventor： Yuanpang Samuel Ding ,  Ying-Cheng Lo

    IPC: B01D61/24

    CPC classification number: B01D61/30 ,  A61M1/1696 ,  A61M1/284 ,  A61M1/287

    Abstract: Dialysis treatment devices and methods for removing urea from dialysis waste streams are provided. In a general embodiment, the present disclosure provides a dialysis treatment device including: 1) a first filter having a filtration membrane, 2) a urea removal unit having urease and in fluid communication with the first filter, and 3) a second filter having an ion rejection membrane and in fluid communication with the first filter and the urea removal unit.

    Abstract translation: 提供了用于从透析废物流中除去尿素的透析治疗装置和方法。 在一般实施例中，本发明提供一种透析治疗装置，其包括：1）具有过滤膜的第一过滤器，2）具有脲酶并与第一过滤器流体连通的尿素去除单元，以及3）具有 离子排斥膜并与第一过滤器和尿素去除单元流体连通。

    THERAPY PREDICTION AND OPTIMIZATION FOR RENAL FAILURE BLOOD THERAPY, ESPECIALLY HOME HEMODIALYSIS
    32.
    发明申请
    THERAPY PREDICTION AND OPTIMIZATION FOR RENAL FAILURE BLOOD THERAPY, ESPECIALLY HOME HEMODIALYSIS 有权
    治疗失败血液治疗的治疗预防和优化，特别是家庭心脏病学

    公开(公告)号：US20120029324A1

    公开(公告)日：2012-02-02

    申请号：US13088064

    申请日：2011-04-15

    Applicant: Alp Akonur ,  John Kenneth Leypoldt ,  Ying-Cheng Lo ,  Baris Ugur Agar

    Inventor： Alp Akonur ,  John Kenneth Leypoldt ,  Ying-Cheng Lo ,  Baris Ugur Agar

    IPC: A61B5/15

    CPC classification number: A61M1/1603 ,  A61M1/16 ,  A61M1/1611 ,  A61M1/1613 ,  A61M1/1619 ,  A61M1/3609 ,  A61M2202/0498 ,  A61M2205/15 ,  A61M2205/3584 ,  A61M2205/50 ,  A61M2205/502 ,  A61M2205/52 ,  A61M2230/20 ,  G06F19/3481

    Abstract: A method of predicting serum phosphorus concentrations in a patient during hemodialysis includes measuring serum phosphorus concentrations of the patient over a hemodialysis treatment session time and an ultrafiltration rate calculated by a difference between pre- and post-dialytic body weight of the patient during an initial hemodialysis treatment session divided by a total treatment time of the treatment session and estimating a phosphorous mobilization clearance and a pre-dialysis distribution volume of phosphorus for the patient. Serum phosphorus concentrations of the patient can then be predicted at any time during any hemodialysis treatment session with the estimated phosphorous mobilization clearance and pre-dialysis distribution volume of phosphorus of the patient.

    Abstract translation: 在血液透析期间预测患者血清磷浓度的方法包括测量血液透析治疗会话时间的患者的血清磷浓度，以及通过初始血液透析期间患者的透析前和透析后体重之间的差异计算的超滤率 治疗时间除以治疗会话的总治疗时间，并估计患者的磷的移动清除率和磷酸盐的透析前分布体积。 然后可以在任何血液透析治疗期间的任何时间预测患者的血清磷浓度，其中估计磷移动清除率和患者的磷的透析前分布体积。

    SIMPLIFIED PERITONEAL EQUILIBRATION TEST FOR PERITONEAL DIALYSIS
    34.
    发明申请
    SIMPLIFIED PERITONEAL EQUILIBRATION TEST FOR PERITONEAL DIALYSIS 有权
    简单的PERITONEAL EQUILIBRATION测试用于腹膜透析

    公开(公告)号：US20110010101A1

    公开(公告)日：2011-01-13

    申请号：US12498847

    申请日：2009-07-07

    Applicant: Ying-Cheng Lo ,  Alp Akonur ,  Sarah Stobo Prichard

    Inventor： Ying-Cheng Lo ,  Alp Akonur ,  Sarah Stobo Prichard

    IPC: G06F19/00

    CPC classification number: A61M1/28 ,  A61M1/1619

    Abstract: A simplified peritoneal equilibration test (S-PET) is disclosed. Instead of a lengthy peritoneal equilibration test (PET), the simplified procedure requires no blood sample and may use data from as few as two or three samples to classify a peritoneal membrane of a user. Typically, a peritoneal membrane or peritoneum of a dialysis patient, or other person, is classed as a high transport membrane, high-average transport membrane, a low-average transport membrane or a low transporter membrane. The S-PET may be performed at home by a user without the need to submit a blood sample. Kits for analyzing the samples may be furnished for home use. The kits may use disposable strips, microfluidic analyzers or chemical reagents, or may alternatively include reusable analysis equipment, such as optical or conductivity analysis equipment.

    Abstract translation: 公开了一种简化的腹膜平衡试验（S-PET）。 代替长时间的腹膜平衡试验（PET），简化的程序不需要血液样品，并且可以使用少至两个或三个样品的数据来分类用户的腹膜。 通常，透析患者或其他人的腹膜或腹膜被分类为高运输膜，高平均运输膜，低平均运输膜或低转运膜。 S-PET可以由用户在家进行，而不需要提交血样。 用于分析样品的试剂盒可供家庭使用。 试剂盒可以使用一次性条，微流控分析仪或化学试剂，或者可以替代地包括可重复使用的分析设备，例如光学或电导率分析设备。

    DIALYSIS TREATMENT DEVICES FOR REMOVING UREA
    35.
    发明申请
    DIALYSIS TREATMENT DEVICES FOR REMOVING UREA 有权
    用于去除尿素的DIALYSIS治疗装置

    公开(公告)号：US20100314314A1

    公开(公告)日：2010-12-16

    申请号：US12482869

    申请日：2009-06-11

    Applicant: Yuanpang Samuel Ding ,  Ying-Cheng Lo

    Inventor： Yuanpang Samuel Ding ,  Ying-Cheng Lo

    IPC: B01D61/32 ,  B01D61/04 ,  B01D61/28

    CPC classification number: B01D61/30 ,  A61M1/1696 ,  A61M1/284 ,  A61M1/287

    Abstract: Dialysis treatment devices and methods for removing urea from dialysis waste streams are provided. In a general embodiment, the present disclosure provides a dialysis treatment device including: 1) a first filter having a filtration membrane, 2) a urea removal unit having urease and in fluid communication with the first filter, and 3) a second filter having an ion rejection membrane and in fluid communication with the first filter and the urea removal unit.

    Abstract translation: 提供了用于从透析废物流中除去尿素的透析治疗装置和方法。 在一般实施例中，本发明提供一种透析治疗装置，其包括：1）具有过滤膜的第一过滤器，2）具有脲酶并与第一过滤器流体连通的尿素去除单元，以及3）具有 离子排斥膜并与第一过滤器和尿素去除单元流体连通。

    SIMULATION OF PATIENT DRAIN PHASE IN PERITONEAL DIALYSIS
    36.
    发明申请
    SIMULATION OF PATIENT DRAIN PHASE IN PERITONEAL DIALYSIS 有权
    腹膜透析患者浸液相的模拟

    公开(公告)号：US20100217180A1

    公开(公告)日：2010-08-26

    申请号：US12389886

    申请日：2009-02-20

    Applicant: Alp Akonur ,  Ying-Cheng Lo

    Inventor： Alp Akonur ,  Ying-Cheng Lo

    IPC: A61M1/28 ,  G06F17/10 ,  G06G7/57 ,  G06G7/60

    CPC classification number: G16H50/50 ,  A61M1/28 ,  A61M1/282

    Abstract: A method of modeling a patient's peritoneal dialysis drain phase includes (i) modeling a first segment of a drain phase curve as having a constant flowrate; (ii) modeling a second segment of a drain phase curve as having a decaying exponential flowrate; and (iii) incorporating a switching component into the first and second components so that (a) at a first time the first segment is active and while the second segment is inactive and (b) at a second time the first segment is inactive and while the second segment is active.

    Abstract translation: 建模患者腹膜透析排泄阶段的方法包括（i）将排水相曲线的第一段建模为具有恒定的流速; （ii）将排水相曲线的第二段建模为具有衰减指数流速; 以及（iii）将切换组件并入到所述第一和第二组件中，使得（a）在第一时间第一段处于活动状态，而第二段处于非活动状态，并且（b）在第二时间段，第一段无效，而 第二段是活跃的。

    TRANSFER SETS FOR THERAPY OPTIMIZATION
    37.
    发明申请
    TRANSFER SETS FOR THERAPY OPTIMIZATION 有权
    转移治疗方案优化

    公开(公告)号：US20100198138A1

    公开(公告)日：2010-08-05

    申请号：US12696889

    申请日：2010-01-29

    Applicant: Paul R. Chapman ,  Brian J. Connell ,  Ying-Cheng Lo

    Inventor： Paul R. Chapman ,  Brian J. Connell ,  Ying-Cheng Lo

    IPC: A61M39/28 ,  A61M1/28

    CPC classification number: A61M1/285 ,  A61M39/12 ,  A61M39/28 ,  A61M39/286

    Abstract: Transfer sets are disclosed in the present patent. The transfer set provides a connection between a source of peritoneal dialysis fluid and a patient for whom peritoneal dialysis has been prescribed. The transfer sets disclosed herein are smaller and provide a more compact and convenient device by which a dialysis patient controls the flow of dialysis fluid to and from the peritoneum of the patient. The devices are more compact and convenient because they include more convenient mechanisms for starting and stopping flow of the dialysis fluid. It is also easy to determine whether the mechanism is in a closed or open configuration by simply looking at the mechanism.

    Abstract translation: 转让集合在本专利中公开。 转移组提供腹膜透析液源和已经规定了腹膜透析的患者之间的连接。 本文公开的转移组较小，并且提供更紧凑和方便的装置，通过该装置透析患者控制透过液流入和离开患者腹膜的流动。 这些装置更紧凑和便利，因为它们包括更方便的起始和停止透析液流动的机构。 通过简单地查看机制，也很容易确定机制是否处于关闭或打开配置。

    DRAIN AND FILL LOGIC FOR AUTOMATED PERITONEAL DIALYSIS
    38.
    发明申请
    DRAIN AND FILL LOGIC FOR AUTOMATED PERITONEAL DIALYSIS 有权
    用于自动化透析的排水和填充逻辑

    公开(公告)号：US20100191181A1

    公开(公告)日：2010-07-29

    申请号：US12362259

    申请日：2009-01-29

    Applicant: Robert W. Childers ,  Peter A. Hopping ,  Ying-Cheng Lo

    Inventor： Robert W. Childers ,  Peter A. Hopping ,  Ying-Cheng Lo

    IPC: A61M1/28

    CPC classification number: A61M1/284 ,  A61M1/28 ,  A61M1/281 ,  A61M1/282 ,  A61M2205/3379 ,  B01D61/30 ,  B01D61/32

    Abstract: A system and method for automatically adjusting a Continuous Cycling Peritoneal Dialysis (“CCPD”) therapy to minimize the potential for excess intra-peritoneal volume. The adjustments are made at the end of the drain, just prior to the next fill. The adjustments short the next fill, if necessary, to limit the intra-peritoneal volume, add a cycle, if necessary, to use all of the available dialysis solution and will average the remaining dwell time to maximize the therapeutic benefit of the therapy in the allotted time. In another embodiment, a tidal therapy using trended patient UF data is provided.

    Abstract translation: 一种用于自动调节连续循环腹膜透析（“CCPD”）治疗的系统和方法，以最大限度地减少腹膜内多余的体积。 调整是在排水结束时进行的，就在下一次填充之前。 如果需要，调整缩短下一次填充，以限制腹膜内体积，如果需要，添加一个循环，以使用所有可用的透析溶液，并将平均剩余停留时间，以最大化治疗的治疗效果 分配时间 在另一个实施例中，提供使用趋势化患者UF数据的潮汐治疗。

    DIALYSIS MACHINE HAVING AUTO-CONNECTION SYSTEM WITH ROLLER OCCLUDER
    39.
    发明申请
    DIALYSIS MACHINE HAVING AUTO-CONNECTION SYSTEM WITH ROLLER OCCLUDER 有权
    具有滚筒式自动连接系统的DIALYSIS MACHINE

    公开(公告)号：US20100130920A1

    公开(公告)日：2010-05-27

    申请号：US12275982

    申请日：2008-11-21

    Applicant: Ying-Cheng Lo ,  Yuanpang Samuel Ding

    Inventor： Ying-Cheng Lo ,  Yuanpang Samuel Ding

    IPC: A61M1/28 ,  B01D61/32

    CPC classification number: A61M1/28 ,  A61M39/20 ,  A61M2205/10 ,  A61M2205/12 ,  A61M2205/121 ,  A61M2205/505 ,  A61M2205/7536

    Abstract: A medical fluid or dialysis system includes an auto-connection mechanism that connects connectors from the supply bags to dialysis cassette ports or cassette supply lines. The system provides for multiple, e.g., four, supply bags, which can be connected to a manifold of the auto-connection mechanism. Tip protecting caps that protect the supply line ends and cassette ports or cassette supply line ends are made to be compatible with the auto-connection mechanism. The auto-connection mechanism removes all the caps and connects the supply lines to the cassette. At least one roller occluder is provided that occludes the supply tubing prior to the tip protecting caps being removed. The roller occludes prevent medical dialysis fluid from spilling out of the supply lines between the time that the caps are removed and connection to the cassette is made.

    Abstract translation: 医疗液体或透析系统包括将供应袋的连接器连接到透析盒端口或盒式电源线的自动连接机构。 该系统提供多个例如四个供应袋，其可以连接到自动连接机构的歧管。 保护电源线端头和磁带盒端口或磁带盒供电线端头的保护帽与自动连接机构兼容。 自动连接机构移除所有盖子并将供应线连接到盒式磁带。 提供至少一个辊封闭器，其在尖端保护盖被移除之前封闭供应管。 滚筒阻塞防止医用透析液从盖子被移除的时间和连接到盒子之间溢出供应管线。

Patent Agency Ranking